Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600–Mutant Unresectable or Metastatic Melanoma

Reinhard Dummer, Dirk Schadendorf, Mario Mandalà et al.|Zurich Open Repository and Archive (University of Zurich)|2022

Cited by 146